Establishment Labs Holdings (ESTA) Research & Development (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Research & Development came in at $5.2 million in Q1 2026, up 3.68% year-on-year from $5.1 million in Q1 2025, and down 3.55% quarter-over-quarter from $5.4 million in Q4 2025.
Establishment Labs Holdings (ESTA) Research & Development (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Research & Development history runs 10 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- On a quarterly basis, Research & Development rose 3.68% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $20.4 million, a 0.27% change from a year earlier, with the FY2025 full-year figure at $20.2 million, up 2.75% from the prior year.
- Research & Development fell to $5.2 million in Q1 2026 per ESTA's latest filing, from $5.4 million in the prior quarter.
- Across five years, Research & Development topped out at $7.1 million in Q3 2023 and bottomed at $3.6 million in Q1 2022.
- The 5-year median for Research & Development is $5.2 million (2026), against an average of $5.4 million.
- Across the five-year window, Research & Development surged 81.57% in 2023 and tumbled 34.59% in 2024, its largest moves.
- Year by year, Research & Development stood at $6.5 million in 2022, then declined by 10.17% to $5.8 million in 2023, then dropped by 11.62% to $5.1 million in 2024, then grew by 5.64% to $5.4 million in 2025, then declined by 3.55% to $5.2 million in 2026.
- Per Business Quant, the three latest ESTA Research & Development figures stand at $5.2 million (Q1 2026), $5.4 million (Q4 2025), and $4.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 5.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 5.20 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 5.49 Mn |
| Mar 31, 2024 | 4.27 Mn |
| Dec 31, 2023 | 5.82 Mn |
| Sep 30, 2023 | 7.13 Mn |
| Jun 30, 2023 | 6.95 Mn |
| Mar 31, 2023 | 6.53 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Sep 30, 2022 | 5.29 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 6.03 Mn |
| Sep 30, 2021 | 3.88 Mn |
| Jun 30, 2021 | 4.35 Mn |